CLINICAL_TRIALS trial_result · 2014-10-30

Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma [Phase 2]

Summary

This clinical trial update reports results from a Phase 2 study evaluating the combination of chemotherapy and rituximab in patients with untreated mantle cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-10-30